All News

NEW ORLEANS -- A brightly colored, attractively packaged household cleaning product called Fabuloso has led to a rash of emergency department visits for accidental ingestion, toxicology researchers reported here.

LONDON -- There's more evidence that vitamin D is protective against breast cancer progression, but the relationship remains less than definitive, researchers here said.

BOSTON -- Compared with the cardiovascular benefits of finfish and shellfish, fears of mercury and polychlorinated biphenyls (PCBs) should be considered dead in the water, according to a review of the evidence.

YOKOHAMA, Japan -- The antioxidant enzyme heme oxygenase-1 may be a potential biomarker or even treatment for silicosis, according to researchers here.

NEW ORLEANS -- CT scans for patients with suspected acute appendicitis add no diagnostic value and may be associated with worse outcomes, researchers reported here.

TORONTO -- Necrotizing fasciitis may be caused by methicillin-resistant Staphylococcus aureus, especially in areas where community-acquired MRSA is prevalent, researchers reported here.

DALLAS -- CT imaging of coronary calcification by electron beam or multidetector devices is appropriate for patients at an intermediate risk, according to an American Heart Association statement. It represents an about face for the organization.

GAINESVILLE, Fla. -- Decaffeinated java at specialty coffee shops, such as Starbucks, and other food outlets may not be free of caffeine, reported researchers here.

LOS ANGELES -- Two of three atypical antipsychotic drugs were no better than placebo at quieting aggression, psychosis, and agitation in patients with Alzheimer's disease, found a multicenter trial. Overall, adverse effects of all three outweighed the benefits.

BOSTON -- National standards for hospital room decontamination do not completely prevent transmission of antibiotic-resistant infections, according to a federally sponsored study.

WINSTON-SALEM, N.C. -- With the echoes of the Institute of Medicine's unrestrained critique of the FDA last month still resounding, two more broadsides calling for major reform were fired today at the beleaguered agency.